These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3824490)

  • 1. Effect of sequential grafting of antigenetically different allografts on the immune response of the host.
    Hopt UT; Mellert J; Thiede K; Kopp T; Müller GH; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 1):324-7. PubMed ID: 3824490
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sponge matrix allografts for concurrent monitoring of immunologic and pharmacologic events at a graft site.
    Sirinek LP; Zinn NE; Ferguson RM; Orosz CG
    Transplantation; 1987 Jul; 44(1):161-4. PubMed ID: 3603678
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferonogenicity of antigens and "early" cytotoxicity of lymphocytes.
    Svet-Moldavsky GJ; Nemirovskaya BM; Osipova TV; Slavina EG; Zinzar SN; Karmanova NV; Morozova LF
    Folia Biol (Praha); 1974; 20(4):225-30. PubMed ID: 4413935
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunopharmacological studies of ribavirin, a broad-spectrum antiviral agent.
    Borghi C; Allegrucci M; Ballerini P; Bianchi R; Puccetti P; Romani L; Fioretti MC
    Chemioterapia; 1987 Jun; 6(2 Suppl):660-3. PubMed ID: 3509519
    [No Abstract]   [Full Text] [Related]  

  • 5. Profile of cytokine production within the rejecting allograft.
    Ford HR; Hoffman RA; Wang SA; Simmons RL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):251-2. PubMed ID: 1990526
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Ohta Y; Nishihara M; Hasuike Y; Kanai T; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):354. PubMed ID: 7533407
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response to fresh meniscal allografts in mice.
    Ochi M; Ishida O; Daisaku H; Ikuta Y; Akiyama M
    J Surg Res; 1995 May; 58(5):478-84. PubMed ID: 7745959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
    [No Abstract]   [Full Text] [Related]  

  • 14. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice.
    Donckier V; Abramowicz D; Bruyns C; Florquin S; Vanderhaeghen ML; Amraoui Z; Dubois C; Vandenabeele P; Goldman M
    J Immunol; 1994 Sep; 153(6):2361-8. PubMed ID: 8077653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunogenicity of tooth allografts in mice].
    Yang C; Dong Y; Zhong L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):158-60. PubMed ID: 10680527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.